6 kensington avenue, gosforth, newcastle upon tyne, NE3 2HP
Website
-
halls pharmacy ( north east ) limitedEstimated Valuation
£297.2k
Pomanda estimates the enterprise value of HALLS PHARMACY ( NORTH EAST ) LIMITED at £297.2k based on a Turnover of £591.1k and 0.5x industry multiple (adjusted for size and gross margin).
halls pharmacy ( north east ) limitedEstimated Valuation
£317.8k
Pomanda estimates the enterprise value of HALLS PHARMACY ( NORTH EAST ) LIMITED at £317.8k based on an EBITDA of £82k and a 3.87x industry multiple (adjusted for size and gross margin).
halls pharmacy ( north east ) limitedEstimated Valuation
£800.8k
Pomanda estimates the enterprise value of HALLS PHARMACY ( NORTH EAST ) LIMITED at £800.8k based on Net Assets of £340.9k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Halls Pharmacy ( North East ) LimitedOverview
Halls Pharmacy ( North East ) Limited is a live company located in newcastle upon tyne, NE3 2HP with a Companies House number of 08323223. It operates in the other human health activities sector, SIC Code 86900. Founded in December 2012, it's largest shareholder is
shorifa razzak & abdur razzak
with a 50% stake. Halls Pharmacy ( North East ) Limited is a established,
small sized company, Pomanda has estimated its turnover at
£591.1k with
declining
growth in recent years.
Halls Pharmacy ( North East ) Limited Health Check
Pomanda's financial health check has awarded Halls Pharmacy ( North East ) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
3 Strong
4 Regular
5 Weak
Size
annual sales of £591.1k, make it in line with the average company (£728.4k)
£591.1k - Halls Pharmacy ( North East ) Limited
£728.4k - Industry AVG
Growth
3 year (CAGR) sales growth of -26%, show it is growing at a slower rate (7.2%)
-26% - Halls Pharmacy ( North East ) Limited
7.2% - Industry AVG
Production
with a gross margin of 38.6%, this company has a comparable cost of product (38.6%)
38.6% - Halls Pharmacy ( North East ) Limited
38.6% - Industry AVG
Profitability
an operating margin of 7% make it more profitable than the average company (5.2%)
7% - Halls Pharmacy ( North East ) Limited
5.2% - Industry AVG
Employees
with 12 employees, this is below the industry average (18)
12 - Halls Pharmacy ( North East ) Limited
18 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
£26.5k - Halls Pharmacy ( North East ) Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £49.3k, this is equally as efficient (£45.8k)
£49.3k - Halls Pharmacy ( North East ) Limited
£45.8k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (20 days)
6 days - Halls Pharmacy ( North East ) Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 100 days, this is slower than average (18 days)
100 days - Halls Pharmacy ( North East ) Limited
18 days - Industry AVG
Stock Days
it holds stock equivalent to 64 days, this is more than average (13 days)
64 days - Halls Pharmacy ( North East ) Limited
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 30 weeks, this is less cash available to meet short term requirements (126 weeks)
30 weeks - Halls Pharmacy ( North East ) Limited
126 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 83.9%, this is a higher level of debt than the average (22.4%)
83.9% - Halls Pharmacy ( North East ) Limited
22.4% - Industry AVG
HALLS PHARMACY ( NORTH EAST ) LIMITED financials
EXPORT
Halls Pharmacy ( North East ) Limited's latest turnover from March 2024 is estimated at £591.1 thousand and the company has net assets of £340.9 thousand. According to their latest financial statements, Halls Pharmacy ( North East ) Limited has 12 employees and maintains cash reserves of £66.5 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Turnover
591,096
704,324
767,652
1,456,392
1,466,248
1,299,572
1,170,652
1,244,677
2,409,655
2,585,838
2,483,872
Other Income Or Grants
Cost Of Sales
363,004
439,864
488,875
957,839
937,039
845,595
737,206
759,514
1,502,654
1,609,231
1,539,773
Gross Profit
228,092
264,460
278,777
498,553
529,209
453,977
433,446
485,162
907,001
976,607
944,098
Admin Expenses
186,657
255,243
124,897
333,783
385,189
339,320
264,506
320,366
742,830
981,297
862,911
Operating Profit
41,435
9,217
153,880
164,770
144,020
114,657
168,940
164,796
164,171
-4,690
81,187
Interest Payable
153,418
109,902
74,676
65,555
62,674
74,011
75,967
76,454
40,290
Interest Receivable
3,021
3,409
515
24
18
88
48
36
63
43
25
Pre-Tax Profit
-108,962
-97,276
79,719
99,238
81,364
40,733
93,021
88,379
123,944
-4,647
81,212
Tax
-15,147
-18,855
-15,459
-7,739
-17,674
-17,676
-24,789
-18,679
Profit After Tax
-108,962
-97,276
64,572
80,383
65,905
32,994
75,347
70,703
99,155
-4,647
62,533
Dividends Paid
Retained Profit
-108,962
-97,276
64,572
80,383
65,905
32,994
75,347
70,703
99,155
-4,647
62,533
Employee Costs
317,779
276,032
215,265
208,674
204,471
200,462
171,969
192,676
1,375,231
1,507,328
1,452,711
Number Of Employees
12
11
9
9
9
9
8
9
65
69
67
EBITDA*
82,004
50,470
195,969
205,937
186,004
157,637
213,133
239,696
210,196
44,721
132,446
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Tangible Assets
260,279
17,326
21,129
16,935
20,652
25,186
30,716
37,459
39,069
47,644
55,236
Intangible Assets
337,048
374,498
411,948
449,398
486,848
524,298
561,748
599,198
636,648
674,098
711,548
Investments & Other
1,149,092
1,149,092
1,149,092
1,149,092
1,149,092
1,149,092
1,149,092
1,149,092
1,149,092
1,149,092
Debtors (Due After 1 year)
Total Fixed Assets
1,746,419
1,540,916
1,582,169
1,615,425
1,656,592
1,698,576
1,741,556
1,785,749
1,824,809
1,870,834
766,784
Stock & work in progress
64,376
45,962
42,079
39,372
44,376
38,893
38,556
45,228
56,216
52,107
59,949
Trade Debtors
10,106
37,604
48,086
157,457
175,103
162,761
161,474
172,197
187,449
188,583
173,117
Group Debtors
Misc Debtors
226,165
Cash
66,473
48,596
111,833
25,527
21,631
14,893
8,497
10,565
18,278
7,103
9,967
misc current assets
total current assets
367,120
132,162
201,998
222,356
241,110
216,547
208,527
227,990
261,943
247,793
243,033
total assets
2,113,539
1,673,078
1,784,167
1,837,781
1,897,702
1,915,123
1,950,083
2,013,739
2,086,752
2,118,627
1,009,817
Bank overdraft
Bank loan
Trade Creditors
100,231
115,153
124,846
146,456
153,167
132,620
112,585
98,434
118,068
119,774
79,864
Group/Directors Accounts
1,242
2,158
12,158
31,904
48,596
38,350
17,850
47,686
other short term finances
hp & lease commitments
other current liabilities
11,285
16,148
42,654
51,899
28,711
22,924
31,269
16,580
27,019
total current liabilities
112,758
133,459
179,658
198,355
213,782
204,140
182,204
132,864
192,773
119,774
79,864
loans
1,638,884
1,088,542
1,055,891
1,156,735
992,603
1,062,296
1,130,624
1,206,820
1,239,701
hp & lease commitments
Accruals and Deferred Income
other liabilities
20,000
288,984
312,327
333,837
445,937
497,137
1,940,867
867,320
provisions
990
1,208
1,473
118
143
175
227
274
total long term liabilities
1,659,874
1,089,750
1,057,364
1,156,853
1,281,730
1,374,798
1,464,688
1,653,031
1,736,838
1,940,867
867,320
total liabilities
1,772,632
1,223,209
1,237,022
1,355,208
1,495,512
1,578,938
1,646,892
1,785,895
1,929,611
2,060,641
947,184
net assets
340,907
449,869
547,145
482,573
402,190
336,185
303,191
227,844
157,141
57,986
62,633
total shareholders funds
340,907
449,869
547,145
482,573
402,190
336,185
303,191
227,844
157,141
57,986
62,633
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Operating Activities
Operating Profit
41,435
9,217
153,880
164,770
144,020
114,657
168,940
164,796
164,171
-4,690
81,187
Depreciation
3,119
3,803
4,639
3,717
4,534
5,530
6,743
37,450
8,575
11,961
13,809
Amortisation
37,450
37,450
37,450
37,450
37,450
37,450
37,450
37,450
37,450
37,450
37,450
Tax
-15,147
-18,855
-15,459
-7,739
-17,674
-17,676
-24,789
-18,679
Stock
18,414
3,883
2,707
-5,004
5,483
337
-6,672
-10,988
4,109
-7,842
59,949
Debtors
198,667
-10,482
-109,371
-17,646
12,342
1,287
-10,723
-15,252
-1,134
15,466
173,117
Creditors
-14,922
-9,693
-21,610
-6,711
20,547
20,035
14,151
-19,634
-1,706
39,910
79,864
Accruals and Deferred Income
-4,863
-26,506
-9,245
23,188
5,787
-8,345
14,689
-10,439
27,019
Deferred Taxes & Provisions
-218
-265
1,355
-25
-32
-52
-47
274
Cash flow from operations
-155,080
20,605
257,986
226,184
179,022
159,912
241,647
218,461
207,745
77,007
-39,435
Investing Activities
capital expenditure
-246,072
-8,833
-35,840
-4,369
-818,043
Change in Investments
1,149,092
cash flow from investments
-246,072
-8,833
-35,840
-1,153,461
-818,043
Financing Activities
Bank loans
Group/Directors Accounts
-916
-10,000
12,158
-31,904
-16,692
10,246
20,500
-29,836
47,686
Other Short Term Loans
Long term loans
550,342
32,651
-100,844
164,132
-69,693
-68,328
-76,196
-32,881
1,239,701
Hire Purchase and Lease Commitments
other long term liabilities
20,000
-288,984
-23,343
-21,510
-112,100
-51,200
-1,443,730
1,073,547
867,320
share issue
100
100
interest
-150,397
-106,493
-74,161
-65,531
-62,656
-73,923
-75,919
-76,418
-40,227
43
25
cash flow from financing
419,029
-83,842
-162,847
-222,287
-172,284
-153,515
-243,715
-190,335
-196,570
1,073,590
867,445
cash and cash equivalents
cash
17,877
-63,237
86,306
3,896
6,738
6,396
-2,068
-7,713
11,175
-2,864
9,967
overdraft
change in cash
17,877
-63,237
86,306
3,896
6,738
6,396
-2,068
-7,713
11,175
-2,864
9,967
halls pharmacy ( north east ) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for halls pharmacy ( north east ) limited. Get real-time insights into halls pharmacy ( north east ) limited's credit score, group structure and payment trends.
Halls Pharmacy ( North East ) Limited Competitor Analysis
Perform a competitor analysis for halls pharmacy ( north east ) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in NE3 area or any other competitors across 12 key performance metrics.
halls pharmacy ( north east ) limited Ownership
HALLS PHARMACY ( NORTH EAST ) LIMITED group structure
Halls Pharmacy ( North East ) Limited has 1 subsidiary company.
HALLS PHARMACY ( NORTH EAST ) LIMITED Shareholders
The largest shareholders in Halls Pharmacy ( North East ) Limited include Shorifa Razzak & Abdur Razzak and Ayaz Akram.
shorifa razzak & abdur razzak
50%
ayaz akram
37.5%
abdur razzak & shorifa razzak
12.5%
halls pharmacy ( north east ) limited directors
Halls Pharmacy ( North East ) Limited currently has 3 directors.
The longest serving directors include
Mr Abdur Razzak (Dec 2012) and
Mr Ayaz Akram (Dec 2012).
halls pharmacy ( north east ) limited company details
company number
08323223
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
December 2012
age
13
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
CALDWELL HOUSE CONSULTING
auditor
-
address
6 kensington avenue, gosforth, newcastle upon tyne, NE3 2HP
Bank
-
Legal Advisor
-
halls pharmacy ( north east ) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to halls pharmacy ( north east ) limited. Currently there are 3 open charges and 3 have been satisfied in the past.
halls pharmacy ( north east ) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HALLS PHARMACY ( NORTH EAST ) LIMITED. This can take several minutes, an email will notify you when this has completed.
halls pharmacy ( north east ) limitedCompanies House Filings - See Documents
